Showing results (111-120 of 145) with videos related to
Sort By:
Pageof 15
Frontiers in Oncology|April 1, 2026
Transperitoneal versus retroperitoneal approach does not alter arterial clamping strategy during robot-assisted partial nephrectomy: interim results from the multicentric PODRACING randomized controlled trialJoris Vangeneugden, Saar Vermijs, Peter De Kuyper, et al.Cancers|June 2, 2021
Immune Monitoring in Melanoma and Urothelial Cancer Patients Treated with Anti-PD-1 Immunotherapy and SBRT Discloses Tumor Specific Immune SignaturesAnnabel Meireson, Simon J Tavernier, Sofie Van Gassen, et al.BMC Cancer|October 19, 2021
Evaluating the impact of 18F-FDG-PET-CT on risk stratification and treatment adaptation for patients with muscle-invasive bladder cancer (EFFORT-MIBC): a phase II prospective trialFlor Verghote, Lindsay Poppe, Sofie Verbeke, et al.Diagnostics (Basel, Switzerland)|October 18, 2017
Prospective Comparison of F-18 Choline PET/CT Scan Versus Axial MRI for Detecting Bone Metastasis in Biochemically Relapsed Prostate Cancer PatientsWouter Huysse, Frédéric Lecouvet, Paolo Castellucci, et al.Healthcare Technology Letters|April 19, 2024
First-in-human real-time AI-assisted instrument deocclusion during augmented reality robotic surgeryJasper Hofman, Pieter De Backer, Ilaria Manghi, et al.BJU International|July 21, 2021
Multicentre, prospective study on local treatment of metastatic prostate cancer (LoMP study)Sarah Buelens, Filip Poelaert, Tom Claeys, et al.JMIR Research Protocols|December 15, 2018
Benefits of Elective Para-Aortic Radiotherapy for pN1 Prostate Cancer Using Arc Therapy (Intensity-Modulated or Volumetric Modulated Arc Therapy): Protocol for a Nonrandomized Phase II TrialCédric Draulans, Steven Joniau, Valérie Fonteyne, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 15, 2017
Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II TrialPiet Ost, Dries Reynders, Karel Decaestecker, et al.BJU International|June 25, 2017
Prevalence and prognosis of low-volume, oligorecurrent, hormone-sensitive prostate cancer amenable to lesion ablative therapyAurélie De Bruycker, Bieke Lambert, Tom Claeys, et al.BJU International|August 10, 2020
Robot-assisted kidney transplantation: update from the European Robotic Urology Section (ERUS) seriesMireia Musquera, Lluis Peri, Tarek Ajami, et al.Pageof 15